This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Abbott Laboratories Corporation. Active years: 1992-1994.
Company Filing History:
Years Active: 1992-1994
Title: Innovations of Mark Littlefield
Introduction
Mark Littlefield is an accomplished inventor based in Arlington Heights, IL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of derivatives and analogs of monoethylglycinexylidide. With a total of two patents to his name, Littlefield's work has the potential to impact medical diagnostics and treatment.
Latest Patents
Littlefield's latest patents focus on the structure and application of substituted monoethylglycinexylidide or its analogs. One of his notable inventions involves a compound where M can be CH.sub.2 NHCH.sub.2 CH.sub.3, CH.sub.2 CH.sub.2 CH.sub.2 CH.sub.3, or CH.sub.2 OCH.sub.2 CH.sub.3. In this invention, one of Y.sup.1 and Y.sup.2 is H, while the other is a protein or a fluorescein moiety chemically bonded to the glycinexylidide or analogue moiety. Additionally, he has disclosed a method for carrying out immunoassays for MEGX, utilizing these compounds as tracers and immunogens.
Career Highlights
Mark Littlefield is currently employed at Abbott Laboratories Corporation, a leading company in the healthcare sector. His work at Abbott has allowed him to further his research and development efforts in innovative pharmaceutical solutions.
Collaborations
Littlefield collaborates with Lawrence Kolaczkowski, contributing to the advancement of their shared projects and enhancing the impact of their inventions.
Conclusion
Mark Littlefield's innovative work in the field of pharmaceuticals showcases his dedication to advancing medical science. His patents and collaborations reflect a commitment to improving healthcare through innovative solutions.